Use of HMG-CoA Reductase Inhibitors after Kidney and Heart Transplantation

• 1 November 1997
• journal article
• Published by Springer Nature in BioDrugs
• Vol. 8  (5) , 387-393
• https://doi.org/10.2165/00063030-199708050-00006

Abstract

Keywords

• TREATMENT
• CORONARY HEART DISEASE
• TRANSPLANTATION
• INHIBITORS
• PRAVASTATIN
• HMG
• CYCLOSPORIN
• KIDNEY AND HEART